Risk assessment of acrylamide in foods

Toxicological Sciences

Volumn 75, Issue 1, 2003, Pages 7-15

  Dybing, Erik ^a   Sanner, T ^b  

^a NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Acrylamide; Cancer; Food exposure; LED10; Risk assessment; T25

Indexed keywords

ACRYLAMIDE; AMIDE; DRINKING WATER; HEMOGLOBIN;

ADOLESCENT; ADULT; AGED; APOPTOSIS; BODY WEIGHT; BREAST ADENOMA; CALCULATION; CANCER RISK; CARCINOGEN DNA INTERACTION; CARCINOGENESIS; CARCINOGENICITY; CELL CYCLE; CHEMICAL CARCINOGENESIS; COFFEE; CONTROLLED STUDY; DETOXIFICATION; DNA REPAIR; ENVIRONMENTAL EXPOSURE; FEMALE; FOOD ANALYSIS; FOOD INTAKE; GENOTOXICITY; HUMAN; IMMUNOSURVEILLANCE; LIFESPAN; LONG TERM EXPOSURE; MALE; MESOTHELIOMA; NONHUMAN; NORWAY; REVIEW; RISK ASSESSMENT; RODENT;

ACRYLAMIDE; ADOLESCENT; ADULT; AGED; ANIMALS; CARCINOGENS; CHILD; FEMALE; FOOD ANALYSIS; FOOD CONTAMINATION; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; QUESTIONNAIRES; RATS; RISK ASSESSMENT; WATER POLLUTANTS, CHEMICAL;

RODENTIA; SCAPTEROMYS AQUATICUS;

EID: 0042028518     PISSN: 10966080     EISSN: None     Source Type: Journal    
DOI: 10.1093/toxsci/kfg165     Document Type: Review

References (51)

1. Abramsson-Zetterberg, L. (2003). The dose-response relationship at very low doses of acrylamide is linear in the flow cytometer-based mouse micronucleus assay. Mutat. Res. 535, 215-222.
2. Adler, I. D., Baumgartner, A., Gonda, H., Friedman, M. A., and Skerhut, M. (2000). 1-Aminobenzotriazole inhibits acrylamide-induced dominant lethal effects in spermatids of male mice. Mutagenesis 15, 133-136.
3. American Cyanamide Company (1989). Chemistry of Acrylamide. Process Chemicals Department, American Cyanamide Company, Wayne, NJ.
4. Bailey, E., Farmer, P. B., Bird, I., Lamb, J. H., and Peal, J. A. (1986). Monitoring exposure to acrylamide by the determination of S-(2-carboxyethyl)cysteine in hydrolyzed hemoglobin by gas chromatography-mass spectrometry. Anal. Biochem. 157, 241-248.
5. Barfknecht, T. R., Mecca, D. J., and Naismith, R. W. (1988). The genotoxic activity of acrylamide. Environ. Mol. Mutagen. 11(Suppl.), 11.
6. Bergmark, E. (1997). Hemoglobin adducts of acrylamide and acrylonitrile in laboratory workers, smokers, and nonsmokers. Chem. Res. Toxicol. 10, 78-84.
7. Bergmark, E., Calleman, C. J., and Costa, L. G. (1991). Formation of hemoglobin adducts of acrylamide and its epoxide metabolite glycidamide in the rat. Toxicol. Appl. Pharmacol. 111, 352-363.
8. Bergmark, E., Calleman, C. J., He, F., and Costa., L. G. (1993). Determination of hemoglobin adducts in humans occupationally exposed to acrylamide. Toxicol. Appl. Pharmacol. 120, 45-54.
9. Bull, R. J., Robinson, M., Laurie, R. D., Stoner, G. D., Greisiger, E., Meier, J. R., and Stober, J. (1984a). Carcinogenic effects of acrylamide in Sencar and A/J mice. Cancer Res. 44, 107-111.
10. Bull, R. J., Robinson, M., and Stober, J. A. (1984b). Carcinogenic activity of acrylamide in the skin and lung of Swiss-ICR mice. Cancer Lett. 24, 209-212.
11. Butterworth, B. E., Eldrigde, S. R., Sprankle, C. S., Working, P. K., Bentley, K. S., and Hurtt, M. E. (1992). Tissue-specific genotoxic effects of acrylamide and acrylonitrile. Environ. Mol. Mutagen. 20, 148-155.
12. Calleman, C. J. (1996). The metabolism and pharmacokinetics of acrylamide: Implications for mechanisms of toxicity and human risk estimation. Drug Metab. Rev. 28, 527-590.
13. Calleman, C. J., Bergmark, E., and Costa, L. G. (1990). Acrylamide is metabolized to glycidamide in the rat: Evidence from hemoglobin adduct formation. Chem. Res. Toxicol. 3, 406-412.
14. Calleman, C. J., Wu, Y., He, F., Tian, G., Bergmark, E., Zhang, S., Deng, H., Wang, Y., Crofton, K. M., Fennell, T., and Costa, L. G. (1994). Relationships between biomarkers of exposure and neurological effects in a group of workers exposed to acrylamide. Toxicol. Appl. Pharmacol. 126, 361-371.
15. Collins, J. J., Swaen, G. M. H., Marsh, G. M., Utidjian, H. M. D., Caporossi, J. C., and Lucas, L. J. (1989). Mortality patterns among workers exposed to acrylamide. J. Occup. Med. 31, 614-617.
16. Dybing, E., Sanner, T., Roelfzema, H., Kroese, D., and Tennant, R. W. (1997). T25: A simplified carcinogenic potency index: Description of the system and study of correlations between carcinogenic potency and species/site specificity and mutagenicity. Pharmacol. Toxicol. 80, 272-279.
17. European Commission (2002). Opinion of the Scientific Committee on Food on new findings regarding the presence of acrylamide in food. http://europa.eu.int/comm/food/fs/sc/scf/out131.pdf
18. EU TGD (2003). Technical Guidance Document on Risk Assessment. 2nd ed. http://ecb.jrc.it/new-chemicals/.
19. Fennel, T. R., Snuder, R. W., Krol, W. L., and Sumner, S. C. J. (2003). Comparison of the hemoglobin adducts formed by administration of N-methylolacrylamide and acrylamide to rats. Toxicol. Sci. 71, 164-175.
20. Friedman, M. A., Dulak, L. H., and Stedham, M. A. (1995). A lifetime oncogenicity study in rats with acrylamide. Fundam. Appl. Toxicol. 27, 95-105.
21. Generoso, W.M., Sega, G. A., Lockhart, A. M., Hughes, L. A., Cain, K. T., Cacheiro, N. L., and Shelby, M. D. (1996). Dominant lethal mutations, heritable translocations, and unscheduled DNA synthesis induced in male mouse germ cells by glycidamide, a metabolite of acrylamide. Mutat. Res. 371, 175-183.
22. Hashimoto, K., and Tanii, H. (1985). Mutagenicity of acrylamide and its analogues in Salmonella typhimurium. Mutat. Res. 158, 129-133.
23. Hoel, D. G., and Portier, C. J. (1994). Nonlinearity of dose-response functions for carcinogenicity. Environ. Health Perspect. 102(Suppl. 1), 109-113.
24. International Agency for Research on Cancer [IARC] (1994). Acrylamide. IARC Monogr. Eval. Carcinog. Risks Hum. 60, 389-433.
25. Johansson, L., Solvoll, K., Bjørneboe, G. E., and Drevon, C. A. (1997). Dietary habits among Norwegian men and women. Scand. J. Nutr. 2, 63-70.
26. Johnson, K., Gorzinski, S., Bodner, K., and Campbell, R. (1984). Acrylamide: A two-year drinking water chronic toxicity-oncogenicity study in Fischer 344 rats. Dow Chemical USA, Midland, MI.
27. Johnson, K. A., Gorzinski, S. J., Bodner, K. M., Campbell, R., Wolf, C. H., Friedman, M. A., and Mast, R. W. (1986). Chronic toxicity and oncogenicity study on acrylamide incorporated in the rinking water of Fischer 344 rats. Toxicol. Appl. Pharmacol. 85, 154-168.
28. Littlefield, N. A., Farmer, J. H., Gaylor, P. W., and Sheldon, W. G. (1979). Effects of dose and time in a long-term, low-dose carcinogenesis study. J. Environ. Pathol. Toxicol. 3, 17-34.
29. Lorentzen, R. J. (1984). FDA procedures for carcinogenic risk assessment. Food Technol. 38, 108-111.
30. Marsh, G. M., Lucasw, L. J., Youk, A. O., and Schall, L. C. (1999). Mortality patterns among workers exposed to acrylamide: 1994 follow up. Occup. Environ. Med. 56, 181-190.
31. Miller, M. J., Carter, D. E., and Sipes, I. G. (1982). Pharmacokinetics of acrylamide in Fischer-344 rats. Toxicol. Appl. Pharmacol. 63, 36-44.
32. Miller, M. S., and Spencer, P. S. (1985). The mechanisms of acrylamide axonopathy. Annu. Rev. Pharmacol. Toxicol. 25, 643-666.
33. Mottram, D. S., Wedzicha, B. L., and Dodson, A. T. (2002). Acrylamide is formed in the Maillard reaction. Nature 419, 448-449.
34. Mucci, L. A., Dickman, P. W., Steineck, G., Adami, H. O., and Augustsson, K. (2003). Dietary acrylamide and cancer of the large bowel, kidney, and bladder: Absence of an association in a population-based study in Sweden. Br. J. Cancer 88, 84-89.
35. Norwegian Food Agency (2002). Risk assessment of acrylamide intake from foods with special emphasis on cancer risk. Oslo, 6 June 2002. Available at http://www.snt.no.
36. Peto, T., Gray, R., Brantom, P., and Grasso, P. (1991). Effects on 4080 rats of chronic ingestion of N-nitrosodiethylamine or N-nitrosodimethylamnie: A detailed dose-response study. Cancer Res. 51, 6415-6451.
37. Robinson, M., Bull, R. J., Knutsen, G. L, Shields, R. P., and Strober, J. A. (1986). A combined bioassay utilizing both the lung adenoma and skin papilloma protocols. Environ. Hlth. Perspect. 68, 141-145.
38. Sanner, T., Dybing, E., Willems, M. I., and Kroese, E. D. (2001). A simple method for quantitative risk assessment of non-threshold carcinogens based on the dose descriptor T25. Pharmacol. Toxicol. 88, 331-341.
39. 14C]acrylamide. Carcinogenesis 16, 1161-1165.
40. Spencer, P. S., and Schaumberg, H. H. (1974a). A review of acrylamide neurotoxicity: I. Properties, uses and human exposure. Can. J. Neurol. Sci. 1, 143-150.
41. Spencer, P. S., and Schaumberg, H. H. (1974b). A review of acrylamide neurotoxicity. Part II. Experimental animal neurotoxicity and pathological mechanisms. Can. J. Neurol. Sci. 1, 152-169.
42. Sobel, W., Bond, G. G., Parsons, T. W., and Brenner, F. E. (1986). Acrylamide cohort mortality study. Brit. J. Ind. Med. 43, 785-788.
43. Stadler, R. H., Blank, I., Varga, N., Robert, F., Hau, J., Guy, P. A., Robert, M. C., and Riediker, S. (2002). Acrylamide from Maillard reaction products. Nature 419, 449.
44. 13C nuclear magnetic resonance spectroscopy. Chem. Res. Toxicol. 5, 81-89.
45. Swedish National Food Agency. Press conference. Uppsala, 24 April 2002. Available at http://www.slv.se.
46. Tareke, E., Rydberg, P., Karlsson, P., Eriksson, S., and Törnqvist, M. (2000). Acrylamide: A cooking carcinogen? Chem. Res. Toxicol. 13, 517-522.
47. Tyl, R. W., Friedman, M. A., Losco, P.E., Fisher, L. C., Johnson, K. A., Strother, D. E., and Wolf, C. H. (2000). Rat two-generation reproduction and dominant lethal study of acrylamide in drinking water. Reprod. Toxicol. 14, 385-401.
48. U.S. Environmental Protection Agency [U.S. EPA] (1996). Proposed guidelines for carcinogen risk assessment. Fed. Reg. 61, 17960-18011.
49. U.S. Environmental Protection Agency [U.S. EPA] (1999). Draft Revised Guidelines for Carcinogen Risk Assessment. USEPA, Washington, DC.
50. 1 in rats. Food Cosmet. Toxicol. 12, 681-685.
51. World Health Organization [WHO] (1996). Guidelines for Drinking-Water Quality. 2nd ed., Vol. 2. Health criteria and other supporting information. International Programme on Chemical Safety, Geneva.